Abbott gets FDA OK for device to treat mitral regurgitation

10/28/2013 | Reuters

Abbott has secured FDA approval for its MitraClip system, designed to treat leaky heart valves caused by mitral regurgitation. The device, which has had marketing approval in Europe since 2008, provides a treatment alternative for patients with the condition who are too weak to undergo open-heart procedures.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC